Erratum to: Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump (Langenbeck's Archives of Surgery, (2010), 395, 1, (65-71), 10.1007/s00423-008-0437-9);Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump

Langenbeck's Archives of Surgery

Volumn 395, Issue 1, 2010, Pages 65-71

  Haveman, Jan Willem ^a   Logtenberg, Susan J J ^a   Kleefstra, Nanne ^a,b   Groenier, Klaas H ^c,d   Bilo, Henk J G ^a,c,d   Blomme, Adri M ^a  

^a ISALA HOSPITAL   (Netherlands)

^b LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Complications; Diabetes mellitus; Insulin infusion systems; Surgery

Indexed keywords

INSULIN;

ADULT; ARTICLE; CATHETER; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY;

EID: 72549100370     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-012-0994-9     Document Type: Erratum

References (17)

1. FL Dunn DM Nathan M Scavini, et al. 1997 Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group Diabetes Care 20 59 63 10.2337/diacare.20.1.59 1:STN:280:DyaK2s7otVGiuw%3D%3D 9028695 doi:10.2337/diacare.20.1.59
2. DM Nathan FL Dunn J Bruch, et al. 1996 Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients Am J Med 100 412 417 10.1016/S0002-9343(97)89516-2 1:CAS:528:DyaK28XislKitrk%3D 8610727 doi:10.1016/S0002-9343(97)89516-2
3. DS Schade RP Eaton W Spencer 1980 Normalization of plasma insulin profiles in diabetic subjects with programmed insulin delivery Diabetes Care 3 9 14 10.2337/diacare.3.1.9 1:CAS:528:DyaL3cXhsVCmsrs%3D 6996975 doi:10.2337/diacare.3.1.9 (Pubitemid 10079146)
4. JL Selam P Micossi FL Dunn, et al. 1992 Clinical trial of programmable implantable insulin pump for type I diabetes Diabetes Care 15 877 885 10.2337/diacare.15.7.877 1:STN:280:DyaK38zoslSktA%3D%3D 1516508 doi:10.2337/diacare.15.7.877
5. C Broussolle N Jeandidier H Hanaire-Broutin 1994 French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society Lancet 343 514 515 10.1016/S0140-6736(94) 91462-1 1:STN:280:DyaK2c7lvVCltQ%3D%3D 7906761 doi:10.1016/S0140-6736(94)91462-1 (Pubitemid 24062286)
6. CD Saudek WC Duckworth A Giobbie-Hurder, et al. 1996 Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group JAMA 276 1322 1327 10.1001/jama.276.16.1322 1:CAS:528:DyaK28XmvFyksL4%3D 8861991 doi:10.1001/jama.276.16.1322 (Pubitemid 26346932)
7. SJ Logtenberg E van Ballegooie H Israel-Bultman, et al. 2007 Glycaemic control, health status and treatment satisfaction with continuous intraperitoneal insulin infusion Neth J Med 65 65 70 1:STN:280: DC%2BD2s7nvVaqtA%3D%3D 17379931
8. JL Selam D Raccah N Jean-Didier, et al. 1992 Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients Diabetes Care 15 53 58 10.2337/diacare.15.1.53 1:STN:280:DyaK387ks1ajsw%3D%3D 1737542 doi:10.2337/diacare.15.1.53
9. R Udelsman H Chen K Loman, et al. 1997 Implanted programmable insulin pumps: one hundred fifty-three patient years of surgical experience Surgery 122 1005 1011 10.1016/S0039-6060(97)90202-6 1:STN:280:DyaK1c%2FoslOqsQ%3D%3D 9426413 doi:10.1016/S0039-6060(97)90202-6 (Pubitemid 28016666)
10. R Udelsman MS Boyne KE Loman, et al. 2000 Intraperitoneal delivery of insulin via mechanical pump: surgical implications Langenbecks Arch Surg 385 367 372 10.1007/s004230000155 1:STN:280:DC%2BD3M7gsVaquw%3D%3D 11127519 doi:10.1007/s004230000155
11. JS Thompson WC Duckworth CD Saudek, et al. 1998 Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group Am J Surg 176 622 626 10.1016/S0002-9610(98)00273-6 1:STN:280:DyaK1M7itl2qsA%3D%3D 9926802 doi:10.1016/S0002-9610(98)00273-6 (Pubitemid 29056662)
12. H Gin E Renard V Melki, et al. 2003 Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience Diabetes Metab 29 602 607 10.1016/S1262-3636(07)70075-7 1:STN:280:DC%2BD2c%2FgvFOjsw%3D%3D 14707889 doi:10.1016/S1262-3636(07)70075-7
13. E Renard P Schaepelynck-Belicar 2007 Implantable insulin pumps. A position statement about their clinical use Diabetes Metab 33 158 166 10.1016/j.diabet.2006.10.004 1:CAS:528:DC%2BD2sXmvFGku7Y%3D 17300973 doi:10.1016/j.diabet.2006.10.004 (Pubitemid 46561386)
14. RO Darouiche 2004 Treatment of infections associated with surgical implants N Engl J Med 350 1422 1429 10.1056/NEJMra035415 1:CAS:528: DC%2BD2cXivVagtrs%3D 15070792 doi:10.1056/NEJMra035415 (Pubitemid 38419996)
15. AJ Moss W Zareba WJ Hall, et al. 2002 Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 877 883 10.1056/NEJMoa013474 11907286 doi:10.1056/NEJMoa013474 (Pubitemid 34984635)
16. MJ Haardt JL Selam G Slama, et al. 1994 A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes Diabetes Care 17 847 851 10.2337/diacare.17.8.847 1:STN:280:DyaK2M%2FksVOitw%3D%3D 7956629 doi:10.2337/diacare.17.8.847 (Pubitemid 24980222)
17. L Dufaitre-patouraux JP Riveline E Renard, et al. 2006 Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study Diabetes Metab 32 427 432 10.1016/S1262-3636(07)70300-2 1:CAS:528:DC%2BD2sXhvVKhtg%3D%3D 17110897 doi:DM-11-2006-32-5-1262-3636-101019- 200519823 (Pubitemid 44836584)